{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:23:18Z","timestamp":1780604598308,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jneuroim.2022.577918","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T11:03:46Z","timestamp":1656155026000},"page":"577918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases"],"prefix":"10.1016","volume":"370","author":[{"given":"Zhang","family":"Weihua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Haitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Changhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Hongzhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xiaotun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jneuroim.2022.577918_bb0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577918_bb0010","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2022.577918_bb0020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0358-9","article-title":"\u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII","volume":"12","author":"Jarius","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0358-9","article-title":"\u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: anti-PKC-gamma, anti-GluR-delta2, anti-ca\/ARHGAP26 and anti-VGCC","volume":"12","author":"Jarius","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0358-9","article-title":"\u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook","volume":"12","author":"Jarius","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577918_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000371","article-title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis","volume":"4","author":"Joubert","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.577918_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108159","article-title":"Long-term seizure outcomes in patients with anti-leucine-rich glioma-inactivated 1 encephalitis","volume":"122","author":"Lin","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577918_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.25310","article-title":"LGI1 and CASPR2 neurological autoimmunity in children","volume":"84","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577918_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper: neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14802\/jmd.20040","article-title":"Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms","volume":"14","author":"Mitoma","year":"2021","journal-title":"J. Mov. Disord."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577918_bb0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain."},{"issue":"46","key":"10.1016\/j.jneuroim.2022.577918_bb0070","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.jneuroim.2022.577918_bb0075","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2022.577918_bb0080","first-page":"203","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis","volume":"17","author":"Qiao","year":"2021","journal-title":"Multi Center Study."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejpn.2017.08.004","article-title":"Limbic encephalitis with LGI1 antibodies in a 14-year-old boy","volume":"22","author":"Schimmel","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577918_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2006.01.033","article-title":"The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1","volume":"49","author":"Schulte","year":"2006","journal-title":"Neuron."},{"key":"10.1016\/j.jneuroim.2022.577918_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.618109","article-title":"Brain magnetic resonance imaging characteristics of anti-leucine-rich glioma-inactivated 1 encephalitis and their clinical relevance: a single-center study in China","volume":"11","author":"Shao","year":"2021","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577918_bb0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/nan.12132","article-title":"LGI1 autoantibodies associated with cerebellar degeneration","volume":"40","author":"Steriade","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577918_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12311-014-0628-6","article-title":"LGI1 is involved in the development of mouse brain","volume":"14","author":"Su","year":"2015","journal-title":"Cerebellum"},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577918_bb0110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s12311-019-01048-y","article-title":"Neurochondrin antibody serum positivity in three cases of autoimmune cerebellar Ataxia","volume":"18","author":"Weihua","year":"2019","journal-title":"Cerebellum."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:16Z","timestamp":1759048876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"alternative-id":["S0165572822001138"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577918","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577918"}}